Imaging Retinal Blood Vessel Disease Over Time With Angiography Scans
Uses eye imaging scans to track retinal vessel disease in adults over time.
Plain-language title generated from the registry record
Registry title: Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
Key facts
- Where
- Baltimore, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Source: NCT04505618, who can take part
Where in United States
- Wilmer Eye InstituteBaltimore, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Johns Hopkins University
- Trial code
- NCT04505618
- Record updated
- 17 June 2026
- Original description
This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.Read full original descriptionShow less
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.
Exclusion: Both subjects with diseases and controls:; History of glaucoma; History of any visually significant eye disease; History of proliferative diabetic retinopathy; History of any inflammatory disease; History of heart disease; History of thyroid disease; History of any type of Diabetes Mellitus; History of any type of Hypertension; Children (age<18); History of age-related macular degeneration; Pregnant females; Developmentally delayed subjects; Subjects unable to provide informed consent; Inability to cooperate with tests and study instructions; Images with motion artifact or signal strength < 7; Additional criteria for controls:.